58 related articles for article (PubMed ID: 24327544)
21. Triptolide overcomes dexamethasone resistance and enhanced PS-341-induced apoptosis via PI3k/Akt/NF-kappaB pathways in human multiple myeloma cells.
Yang M; Huang J; Pan HZ; Jin J
Int J Mol Med; 2008 Oct; 22(4):489-96. PubMed ID: 18813856
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic enhancement of ER stress by insulin-like growth factor I sensitizes myeloma cells to proteasomal inhibitors.
Tagoug I; Jordheim LP; Herveau S; Matera EL; Huber AL; Chettab K; Manié S; Dumontet C
Clin Cancer Res; 2013 Jul; 19(13):3556-66. PubMed ID: 23674497
[TBL] [Abstract][Full Text] [Related]
23. Cytokines prevent dexamethasone-induced apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in a new multiple myeloma cell line.
Ogawa M; Nishiura T; Oritani K; Yoshida H; Yoshimura M; Okajima Y; Ishikawa J; Hashimoto K; Matsumura I; Tomiyama Y; Matsuzawa Y
Cancer Res; 2000 Aug; 60(15):4262-9. PubMed ID: 10945640
[TBL] [Abstract][Full Text] [Related]
24. The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity.
Nakaya A; Sagawa M; Muto A; Uchida H; Ikeda Y; Kizaki M
Leuk Res; 2011 Feb; 35(2):243-9. PubMed ID: 20542334
[TBL] [Abstract][Full Text] [Related]
25. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.
Tu Y; Gardner A; Lichtenstein A
Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064
[TBL] [Abstract][Full Text] [Related]
26. Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.
Jourdan M; Moreaux J; Vos JD; Hose D; Mahtouk K; Abouladze M; Robert N; Baudard M; Rème T; Romanelli A; Goldschmidt H; Rossi JF; Dreano M; Klein B
Br J Haematol; 2007 Jul; 138(2):160-8. PubMed ID: 17542984
[TBL] [Abstract][Full Text] [Related]
27. Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy.
Balsas P; Galán-Malo P; Marzo I; Naval J
Leuk Res; 2012 Feb; 36(2):212-8. PubMed ID: 21978467
[TBL] [Abstract][Full Text] [Related]
28. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.
Cheung WC; Van Ness B
Leukemia; 2002 Jun; 16(6):1182-8. PubMed ID: 12040451
[TBL] [Abstract][Full Text] [Related]
29. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
[TBL] [Abstract][Full Text] [Related]
30. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
French JD; Tschumper RC; Jelinek DF
Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
[TBL] [Abstract][Full Text] [Related]
31. SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling.
Xu J; Sun HY; Xiao FJ; Wang H; Yang Y; Wang L; Gao CJ; Guo ZK; Wu CT; Wang LS
Biochem Biophys Res Commun; 2015 May; 460(2):409-15. PubMed ID: 25791478
[TBL] [Abstract][Full Text] [Related]
32. Constitutive NF-kappaB activation confers interleukin 6 (IL6) independence and resistance to dexamethasone and Janus kinase inhibitor INCB018424 in murine plasmacytoma cells.
Yang Y; Groshong JS; Matta H; Gopalakrishnan R; Yi H; Chaudhary PM
J Biol Chem; 2011 Aug; 286(32):27988-97. PubMed ID: 21705340
[TBL] [Abstract][Full Text] [Related]
33. Autocrine and Paracrine Interactions between Multiple Myeloma Cells and Bone Marrow Stromal Cells by Growth Arrest-specific Gene 6 Cross-talk with Interleukin-6.
Furukawa M; Ohkawara H; Ogawa K; Ikeda K; Ueda K; Shichishima-Nakamura A; Ito E; Imai JI; Yanagisawa Y; Honma R; Watanabe S; Waguri S; Ikezoe T; Takeishi Y
J Biol Chem; 2017 Mar; 292(10):4280-4292. PubMed ID: 28154173
[TBL] [Abstract][Full Text] [Related]
34. Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.
Templin J; Atanackovic D; Hasche D; Radhakrishnan SV; Luetkens T
Oncotarget; 2017 Jul; 8(30):49253-49263. PubMed ID: 28512269
[TBL] [Abstract][Full Text] [Related]
35. The regulatory mechanism of IL-6-dependent proliferation of human myeloma cells.
Tsuyama N; Ishikawa H; Abroun S; Liu S; Li FJ; Otsuyama K; Zheng X; Obata M; Taniguchi O; Kawano MM
Hematology; 2003 Dec; 8(6):409-11. PubMed ID: 14668037
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of proliferation and induction of apoptosis in multiple myeloma cell lines by CD137 ligand signaling.
Gullo C; Koh LK; Pang WL; Ho KT; Tan SH; Schwarz H
PLoS One; 2010 May; 5(5):e10845. PubMed ID: 20520765
[TBL] [Abstract][Full Text] [Related]
37. Novel Interleukin-6 Inducible Gene PDZ-Binding Kinase Promotes Tumor Growth of Multiple Myeloma Cells.
Ota A; Hanamura I; Karnan S; Inaguma S; Takei N; Lam VQ; Mizuno S; Kanasugi J; Wahiduzzaman M; Rahman ML; Hyodo T; Konishi H; Tsuzuki S; Ikeda H; Takami A; Hosokawa Y
J Interferon Cytokine Res; 2020 Aug; 40(8):389-405. PubMed ID: 32721246
[TBL] [Abstract][Full Text] [Related]
38. DKK1 activates noncanonical NF-κB signaling via IL-6-induced CKAP4 receptor in multiple myeloma.
Li X; Wang J; Zhu S; Zheng J; Xie Y; Jiang H; Guo J; Wang Y; Peng Z; Wang M; Wang J; Wang S; Zhong Y; Liu Z
Blood Adv; 2021 Sep; 5(18):3656-3667. PubMed ID: 34470047
[TBL] [Abstract][Full Text] [Related]
39. Inactivation of CK1α in multiple myeloma empowers drug cytotoxicity by affecting AKT and β-catenin survival signaling pathways.
Manni S; Carrino M; Manzoni M; Gianesin K; Nunes SC; Costacurta M; Tubi LQ; Macaccaro P; Taiana E; Cabrelle A; Barilà G; Martines A; Zambello R; Bonaldi L; Trentin L; Neri A; Semenzato G; Piazza F
Oncotarget; 2017 Feb; 8(9):14604-14619. PubMed ID: 28099937
[TBL] [Abstract][Full Text] [Related]
40. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
